Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented…
Aon Announces Strategic Investment in eMed to Scale GLP-1 Population Health Platform
Strategic investment is accelerating the transformation of employer-focused obesity solutions to boost…
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq:…
Sharecare to collaborate with Centers for Medicare & Medicaid Services to improve care quality, accelerate progress in healthcare
Company doubles down on its commitment to transform personal health journey of…
Introducing DXC Assure Risk Management: AI-Powered Claims Solution for Self-Insured Organizations
ASHBURN, Va., July 29, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a…
Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+
July 22, 2025 02:00 ET Â | Source: Scancell Holdings Plc SCOPE trial…
Berlin Heals Announces Publication of Two-Year Clinical Outcomes of Cardiac Microcurrent Therapy in ESC Heart Failure
Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC…
Australian Dentists Endorse Smartee’s Mandibular Repositioning Technology at Global Symposium in Kunming
Clinicians praise the S8-SGTB appliance for accelerating outcomes, improving patient satisfaction, and…
Drger Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation
Dräger recognized for pioneering innovations in respiratory care, delivering measurable improvements in…
CCS Presents Four Peer-Reviewed Posters at American Diabetes Associations 85th Scientific Sessions
CCS’s latest evidence-based research reinforces the most innovative and intelligent approaches to…